Philippines Reports Drug Makers Volunteered Price Cuts On 23 Drugs
This article was originally published in PharmAsia News
The Philippines authorities report that although drug makers fell short of the 21 "essential" medicines whose prices they were asked to cut by 50 percent, they did propose reductions in the prices of 23 other drugs. The National Drug Policy unit of the Health Department is reviewing the 23 additional drugs listed by pharmaceutical companies as those with prices they would cut by 10 percent to 50 percent. The proposals still have to be approved along with a government response to ordered cuts in the prices of the six essential drugs the companies did not volunteer to cut. (Click here for more
You may also be interested in...
Chad Reynolds of RMQ+ spoke to Medtech Insight about practical strategies for managing economic operators efficiently and with a view to long-term compliance.
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.
Join us for an audio catch-up on the latest key developments in the global biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.